Zimmer Announces New Testing Milestone For Vivacit-E Technology
Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is highlighting its Vivacit-E® Advanced Bearing Technology with Vitamin E by celebrating a significant testing milestone.
“As patients for total hip replacements continue to skew younger and more active, it’s more important than ever to provide them a product that offers proven, low-wear stability and durability, and that’s exactly what Vivacit-E Technology does,” said Matt Monaghan, Zimmer Senior Vice President and General Manager, Hips. “By offering a lifetime of wear resistance and the prevention of long-term oxidation, Vivacit-E Advanced Bearing Technology plays a crucial role in making hip replacement technology from Zimmer the industry standard.”
Zimmer’s Vivacit-E Vitamin E Technology has been lab tested to mimic the number of walking steps an implant will typically be subjected to during its lifetime. Based on the average American life expectancy of 78.7 years, a patient who undergoes hip replacement at the age of 45 would need their implant to last for 34 years. Depending on how active a person is, studies have shown that we typically take about 1.1 – 2.2 million walking steps per year. Therefore, the implant would be subjected to between 37 – 74 million steps during its lifetime.
“Because of this incredible longevity and durability, Vivacit-E Liners help make this hip replacement technology the implant of choice for younger and more active patients,” Monaghan added.
Founded in 1927 and headquartered in Warsaw, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer’s 2014 sales were approximately $4.7 billion. The company is supported by the efforts of more than 9,000 employees worldwide. More information about Zimmer is available at www.zimmer.com.